The Indian pharmaceutical industry is a success story now providing employment for millions. A highly regulated sector, the Indian Pharma Industry is growing at about 8 to 9 percent annually and is expected to grow to US$ 12 billion by 2010. The presence of low-cost production facilities and a large science base is helping drive this trend. India is emerging as an attractive destination for clinical trials. Today, the market value of clinical research outsourced to India is estimated at US$ 100 million. The booming healthcare market has opened a window of opportunities in the medical device field, as well. The Indian biotech sector is expected to create about one million jobs by 2010.

To partner our clients as they enter the regulated global markets and consolidate their operations in the domestic pharma marketplace Hy-Flier has in place a team of consultants and researchers. The team at Hy-Flier has executed over some mandates in the last year in diverse areas such as sales and marketing, international sales, manufacturing, operation, research and development, regulatory and quality control for Fortune 500 clients and large Indian corporate in this industry space.